PCLX-001
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PCLX-001, covering 2025-03-10 to 2025-04-17. Get the full timeline:
Most recent: Clinical Trial Update: Study of PCLX-001 in R/R Advanced Solid Malignancies and B-cell Lymphoma [Phase 1]